circ-SKA3 functioned as an oncogene to promote the development of MB by increasing ID3 expression via decoying miR-326, hinting that circ-SKA3 might be a therapeutic target of MB.
Circ-SKA3 upregulates ID3 expression by decoying miR-326 to accelerate the development of medulloblastoma.